Carcinoid Tumor: Clinical Trials

2 trials for Carcinoid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Carcinoid Tumor: new trials by email Literature Review of Carcinoid Tumor trials Research Report on Carcinoid Tumor

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
arginine/lysine - Gastroenteropancreatic Neuroendocrine Tumors
Phase 4CompletedAdvanced Accelerator Applications422021-01-252025-01-24
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Everolimus, Sandostatin LAR Depot - Neoplasms
Phase 4CompletedNovartis Pharmaceuticals342013-05-142021-06-11

Narrower conditions

Neuroendocrine Tumors (2)  ·  Gastro-enteropancreatic neuroendocrine tumor (1)  ·  Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neuroectodermal Tumors (2)  ·  Neoplasms (1)

Interventions

Everolimus (1)  ·  Octreotide (1)  ·  arginyllysine (1)

Sponsors

Advanced Accelerator Applications (1)  ·  Novartis Pharmaceuticals (1)

Countries

Italy (2)  ·  Netherlands (2)  ·  Czechia (1)  ·  Poland (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2019 (1)